Can Apelvis treat lymphangioma?

Alpelisib (Alpelisib) is mainly used to treat breast cancer, especially hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer that carries PIK3CA gene mutations. Currently, Apelvis is not officially approved for the treatment of lymphangioma. Lymphangioma is a rare lymphatic system disease, and treatment is usually determined by a professional doctor based on the condition. Patients should discuss the most appropriate treatment options with their doctor, which may include surgery, laser treatment, sclerotherapy, etc. Treatment of lymphangioma requires comprehensive consideration based on individual condition and decisions made by a professional medical team. If a patient has questions about Apelvis or other medicines, it is recommended to consult a specialist for detailed medical advice.